Adirex Pharma

Adirex Pharma focuses on pharmaceuticals for general health, dermatology, and pediatrics.

About Adirex Pharma

Adirex Pharma is a Healthcare company. Adirex Pharma focuses on pharmaceuticals for general health, dermatology, and pediatrics. The company has 25 employees. Its Indian entity Adirex Pharmaceuticals Private Limited reported revenue of β‚Ή10.41 Cr. Adirex Pharma offers products and services including General Medicines and Dermatology Products. Its focus areas include Pharmaceuticals, Medicines, General Medicines and Dermatology.

Company details

Adirex Pharmaceuticals Pvt. Ltd. is recognized for its dedication to enhancing global health outcomes through the development of affordable medicines. Established in 2016, products in general medicines, dermatology, and pediatrics are created with stringent quality standards to ensure safety and efficacy. Future expansions into areas like cardiology and oncology are anticipated, where innovative treatments for various conditions are planned. A commitment to patient well-being is demonstrated through rigorous testing and distribution practices, addressing diverse healthcare needs worldwide.

Key Metrics
  • Indian entity revenue
    ₹10.41 Cr

    FY 2025 · +42% YoY

  • Indian entity net profit
    ₹48.6 Lakh

    FY 2025 · 5% margin

  • Indian entity EBITDA
    ₹83.2 Lakh

    FY 2025 · 8% margin

  • Employee Count
    25

Products & Services of Adirex Pharma

Adirex Pharma offers a comprehensive portfolio of products and services, including General Medicines and Dermatology Products.

General Medicines
Pharmaceuticals

Medicines for general health concerns are provided to address widespread needs.

Dermatology Products
Skin Care

Products for healthy skin are offered to support overall well-being.

Board of directors of Adirex Pharmaceuticals Private Limited (Adirex Pharma)

Adirex Pharmaceuticals Private Limited is the primary company behind Adirex Pharma. The board of Adirex Pharmaceuticals Private Limited currently have 2 directors; the longest-serving is Rekha Dandapat, appointed in 2015. 2 earlier directors have ceased.

DirectorDesignationAppointedTenureEntity
Rekha Dandapat
DIN 07247741
Director12 Oct 201511 yrsAdirex Pharmaceuticals Private Limited
Debkumar Dandapat
DIN 08222332
Director10 Sep 20188 yrs 1 moAdirex Pharmaceuticals Private Limited

Financials of Adirex Pharma

Figures of Adirex Pharmaceuticals Private Limited, the primary company behind Adirex Pharma, for FY 2025. Revenue was ₹10.41 Cr (+42% year on year). Net profit was ₹48.6 Lakh (5% margin). EBITDA was ₹83.2 Lakh (8% margin). Revenue has grown at a compounded annual rate of +10% over three years and +36% over five years.

  • ₹10.41 CrRevenue · FY 2025 · +42% YoY
  • ₹48.6 LakhNet profit · 5% margin
  • ₹83.2 LakhEBITDA · 8% margin
  • ₹40 LakhPaid-up capital
  • 25Employees (provident fund records)
  • +10%Revenue CAGR, 3 years
  • +36%Revenue CAGR, 5 years

Balance sheet, profit and loss, cash flow and ratios of Adirex Pharmaceuticals Private Limited are on its company page.

Premium access

Detailed financial statements for Adirex Pharma

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Adirex Pharma

Adirex Pharma has 25 employees.

The primary company behind Adirex Pharma, Adirex Pharmaceuticals Private Limited, reported revenue of β‚Ή10.41 Cr for FY 2025, up 42% year on year.

Adirex Pharmaceuticals Pvt. Ltd. is recognized for its dedication to enhancing global health outcomes through the development of affordable medicines. Established in 2016, products in general medicines, dermatology, and pediatrics are created with stringent quality standards to ensure safety and efficacy. Future expansions into areas like cardiology and oncology are anticipated, where innovative treatments for various conditions are planned. A commitment to patient well-being is demonstrated through rigorous testing and distribution practices, addressing diverse healthcare needs worldwide.

Adirex Pharma offers General Medicines and Dermatology Products.

Adirex Pharma operates through Adirex Pharmaceuticals Private Limited.

The legal entities of Adirex Pharma currently have 2 directors, including Rekha Dandapat, Debkumar Dandapat.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available